Clinical Trial Update: A Phase 1 Food Effect Study of Azilsartan (TAK-536) Pediatric Formulation [Phase 1]

View source ↗

Summary

Phase 1 study assessing the food effect of a pediatric formulation of azilsartan (TAK-536) in healthy volunteers; completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy Volunteers

Drugs mentioned

• Azilsartan (azilsartan)

Snippet

Sponsor: Takeda | Conditions: Healthy Volunteers | Phase 1 | Status: COMPLETED | Results posted: 2019-06-07